Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Rik Schoemaker

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Disorders

Concepts & Ideas

Chemicals & Drugs

Phenomena

Metabolic Clearance Rate

Physiology

Liver Circulation

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Zoethout Remco W M; Schoemaker Rik C; Zuurman Lineke; van Pelt Hans; Dahan Albert; Cohen Adam F; van Gerven Joop M A
Central nervous system effects of alcohol at a pseudo-steady-state concentration using alcohol clamping in healthy volunteers.
van Haarst Aernout D; Dijkmans Anneke C; Weimann Hans-Josef; Kemme Michiel J B; Bosch Jacobus J; Schoemaker Rik C; Cohen Adam F; Burggraaf Jacobus
Clinically important interaction between tedisamil and verapamil.
Zoethout Remco W M; van Gerven Joop M A; Dumont Glenn J H; Paltansing Sunita; van Burgel Nathalie D; van der Linden Monique; Dahan Albert; Cohen Adam F; Schoemaker Rik C
A comparative study of two methods for attaining constant alcohol levels.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Rik Schoemaker (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Zoethout Remco W M; Schoemaker Rik C; Zuurman Lineke; van Pelt Hans; Dahan Albert; Cohen Adam F; van Gerven Joop M A
Central nervous system effects of alcohol at a pseudo-steady-state concentration using alcohol clamping in healthy volunteers.
British journal of clinical pharmacology 2009;68(4):524-34.
2009: van Haarst Aernout D; Dijkmans Anneke C; Weimann Hans-Josef; Kemme Michiel J B; Bosch Jacobus J; Schoemaker Rik C; Cohen Adam F; Burggraaf Jacobus
Clinically important interaction between tedisamil and verapamil.
Journal of clinical pharmacology 2009;49(5):560-7.
2008: Zoethout Remco W M; van Gerven Joop M A; Dumont Glenn J H; Paltansing Sunita; van Burgel Nathalie D; van der Linden Monique; Dahan Albert; Cohen Adam F; Schoemaker Rik C
A comparative study of two methods for attaining constant alcohol levels.
British journal of clinical pharmacology 2008;66(5):674-81.
2008: Willemze A J; Cremers S C; Schoemaker R C; Lankester A C; den Hartigh J; Burggraaf J; Vossen J M
Ciclosporin kinetics in children after stem cell transplantation.
British journal of clinical pharmacology 2008;66(4):539-45.
2008: Eustatia-Rutten Carmen F A; Corssmit Eleonora P M; Heemstra Karen A; Smit Johannes W A; Schoemaker Rik C; Romijn Johannes A; Burggraaf Jacobus
Autonomic nervous system function in chronic exogenous subclinical thyrotoxicosis and the effect of restoring euthyroidism.
The Journal of clinical endocrinology and metabolism 2008;93(7):2835-41.
2008: de Haas S L; de Visser S J; van der Post J P; Schoemaker R C; van Dyck K; Murphy M G; de Smet M; Vessey L K; Ramakrishnan R; Xue L; Cohen A F; van Gerven J M A
Pharmacodynamic and pharmacokinetic effects of MK-0343, a GABA(A) alpha2,3 subtype selective agonist, compared to lorazepam and placebo in healthy male volunteers.
Journal of psychopharmacology (Oxford, England) 2008;22(1):24-32.
2007: de Haas S L; de Visser S J; van der Post J P; de Smet M; Schoemaker R C; Rijnbeek B; Cohen A F; Vega J M; Agrawal N G B; Goel T V; Simpson R C; Pearson L K; Li S; Hesney M; Murphy M G; van Gerven J M A
Pharmacodynamic and pharmacokinetic effects of TPA023, a GABA(A) alpha(2,3) subtype-selective agonist, compared to lorazepam and placebo in healthy volunteers.
Journal of psychopharmacology (Oxford, England) 2007;21(4):374-83.
2006: van Doorn Martijn B A; Espirito Santo Sonia M; Meijer Piet; Kamerling Ingrid M; Schoemaker Rik C; Dirsch Verena; Vollmar Angelika; Haffner Thomas; Gebhardt Rolf; Cohen Adam F; Princen Hans M; Burggraaf Jacobus
Effect of garlic powder on C-reactive protein and plasma lipids in overweight and smoking subjects.
The American journal of clinical nutrition 2006;84(6):1324-9.
2006: Rad M; Hümpel M; Schaefer O; Schoemaker R C; Schleuning W-D; Cohen A F; Burggraaf J
Pharmacokinetics and systemic endocrine effects of the phyto-oestrogen 8-prenylnaringenin after single oral doses to postmenopausal women.
British journal of clinical pharmacology 2006;62(3):288-96.
2006: Levitt David G; Schoemaker Rik C
Human physiologically based pharmacokinetic model for ACE inhibitors: ramipril and ramiprilat.
BMC clinical pharmacology 2006;6():1.
2005: Boot J D; Tarasevych S; Sterk P J; Schoemaker R C; Wang L; Amin D; Cohen A F; Diamant Z
Reversal of the late asthmatic response increases exhaled nitric oxide.
Respiratory medicine 2005;99(12):1591-4.
2005: van Doorn Martijn B A; Burggraaf Jacobus; van Dam Tijtje; Eerenberg Anke; Levi Marcel; Hack Cornelis E; Schoemaker Rik C; Cohen Adam F; Nuijens Jan
A phase I study of recombinant human C1 inhibitor in asymptomatic patients with hereditary angioedema.
The Journal of allergy and clinical immunology 2005;116(4):876-83.
2005: Scholten Eduard M; Cremers Serge C L M; Schoemaker Rik C; Rowshani Ajda T; van Kan Erik J; den Hartigh Jan; Paul Leendert C; de Fijter Johan W
AUC-guided dosing of tacrolimus prevents progressive systemic overexposure in renal transplant recipients.
Kidney international 2005;67(6):2440-7.
2005: Jazet I M; Pijl H; Frölich M; Schoemaker R C; Meinders A E
Factors predicting the blood glucose lowering effect of a 30-day very low calorie diet in obese Type 2 diabetic patients.
Diabetic medicine : a journal of the British Diabetic Association 2005;22(1):52-5.
2005: Cohen Judith; Burggraaf Jacobus; Schoemaker Rik C; Sterk Peter J; Cohen Adam F; Diamant Zuzana
Relationship between airway responsiveness to neurokinin A and methacholine in asthma.
Pulmonary pharmacology & therapeutics 2005;18(3):171-6.
2004: Litjens Nicolle H R; Burggraaf Jacobus; van Strijen Elisabeth; van Gulpen Co; Mattie Herman; Schoemaker Rik C; van Dissel Jaap T; Thio H Bing; Nibbering Peter H
Pharmacokinetics of oral fumarates in healthy subjects.
British journal of clinical pharmacology 2004;58(4):429-32.
2004: Zwaveling J; Bubbers S; van Meurs A H J; Schoemaker R C; van Heel I Ruijs-Dudok; Vermeij P; Burggraaf J
Pharmacokinetics of rectal tramadol in postoperative paediatric patients.
British journal of anaesthesia 2004;93(2):224-7.
2004: van der Post J P; de Visser S J; Schoemaker R C; Cohen A F; van Gerven J M A
Pharmacokinetic/pharmacodynamic assessment of tolerance to central nervous system effects of a 3 mg sustained release tablet of rilmenidine in hypertensive patients.
Journal of psychopharmacology (Oxford, England) 2004;18(2):221-7.
2004: Kamerling Ingrid M C; van Haarst Aernout D; Burggraaf Jacobus; Schoemaker Rik C; de Kam Marieke L; Heinzerling Hartmut; Cohen Adam F; Masclee Ad A M
Effects of a nonpeptide motilin receptor antagonist on proximal gastric motor function.
British journal of clinical pharmacology 2004;57(4):393-401.
2003: Pieters M S M; van Steveninck A F; Schoemaker R C; Kroon J M; van Gerven J M A; Cohen A F
The psychomotor effects of carbamazepine in epileptic patients and healthy volunteers.
Journal of psychopharmacology (Oxford, England) 2003;17(3):269-72.
2003: Kemme Michiel J B; vd Post Jeroen P; Schoemaker Rik C; Straub Matthias; Cohen Adam F; van Gerven Joop M A
Central nervous system effects of moxonidine experimental sustained release formulation in patients with mild to moderate essential hypertension.
British journal of clinical pharmacology 2003;55(6):518-25.
2003: Cremers Serge C L M; Scholten Eduard M; Schoemaker Rik C; Lentjes Eef G W M; Vermeij Pieter; Paul Leendert C; den Hartigh Jan; de Fijter Johan W
A compartmental pharmacokinetic model of cyclosporin and its predictive performance after Bayesian estimation in kidney and simultaneous pancreas-kidney transplant recipients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2003;18(6):1201-8.
2003: Kamerling Ingrid M C; Van Haarst Aernout D; Burggraaf Jacobus; Schoemaker Rik C; Biemond Izak; Heinzerling Hartmut; Jones Richard; Cohen Adam F; Masclee Ad A M
Motilin effects on the proximal stomach in patients with functional dyspepsia and healthy volunteers.
American journal of physiology. Gastrointestinal and liver physiology 2003;284(5):G776-81.
2003: Kemme Michiel J B; Burggraaf Jacobus; Schoemaker Rik C; Cohen Adam F; Kluft Cornelis; Chia Stanley; Webb David J; Newby David E
Local tissue factor pathway inhibitor release in the human forearm.
Thrombosis and haemostasis 2003;89(3):438-45.
2003: Kemme Michiel J; Schoemaker Rik C; Burggraaf Jacobus; van der Linden Monique; Noordzij Marina; Moerland Matthijs; Kluft Cornelis; Cohen Adam F
Endothelial binding of recombinant tissue plasminogen activator: quantification in vivo using a recirculatory model.
Journal of pharmacokinetics and pharmacodynamics 2003;30(1):3-22.
2002: Kemme Michiel J B; Burggraaf Jacobus; Schoemaker Rik C; Kluft Cornelis; Cohen Adam F
Quantification of heparin-induced TFPI release: a maximum release at low heparin dose.
British journal of clinical pharmacology 2002;54(6):627-34.
2002: de Visser Saco J; van der Post Jeroen-Paul; Nanhekhan Loyd; Schoemaker Rik C; Cohen Adam F; van Gerven Joop M A
Concentration-effect relationships of two rilmenidine single-dose infusion rates in hypertensive patients.
Clinical pharmacology and therapeutics 2002;72(4):419-28.
2002: Schoemaker Rik C; van dDer Vorst Maria M j; van Heel Isabelle Ruijs-Dudok; Cohen Adam F; Burggraaf Jacobus;
Development of an optimal furosemide infusion strategy in infants with modeling and simulation.
Clinical pharmacology and therapeutics 2002;72(4):383-90.
2002: Weijtens Olga; Schoemaker Rik C; Romijn Fred P H T M; Cohen Adam F; Lentjes Eef G W M; van Meurs Jan C
Intraocular penetration and systemic absorption after topical application of dexamethasone disodium phosphate.
Ophthalmology 2002;109(10):1887-91.
2002: Faaij R A; Burggraaf J; Schoemaker R C; Van Amsterdam R G M; Cohen A F
Absence of an interaction between the synthetic pentasaccharide fondaparinux and oral warfarin.
British journal of clinical pharmacology 2002;54(3):304-8.
2002: Buijs Madelon M; Burggraaf Jacobus; Langendonk Janneke G; Schoemaker Rik C; Frölich Marijke; Arndt Jan-Willem; Cohen Adam F; Romijn Johannes A; Ackermans Mariette T; Sauerwein Hans P; Meinders A Edo; Pijl Hanno
Hyposomatotropism blunts lipolysis in abdominally obese women.
The Journal of clinical endocrinology and metabolism 2002;87(8):3851-8.
2002: de Hoog Matthijs; Schoemaker Rik C; van den Anker John N; Vinks Alexander A
NONMEM and NPEM2 population modeling: a comparison using tobramycin data in neonates.
Therapeutic drug monitoring 2002;24(3):359-65.
2002: van der Post J; Schram M T; Schoemaker R C; Pieters M S M; Fuseau E; Pereira A; Baggen S; Cohen A F; van Gerven J M A
CNS effects of sumatriptan and rizatriptan in healthy female volunteers.
Cephalalgia : an international journal of headache 2002;22(4):271-81.
2002: de Hoog Matthijs; Mouton Johan W; Schoemaker Rik C; Verduin Cees M; van den Anker John N
Extended-interval dosing of tobramycin in neonates: implications for therapeutic drug monitoring.
Clinical pharmacology and therapeutics 2002;71(5):349-58.
2002: Schoemaker Rik C; Buijs Madelon M; Pijl Hanno; Burggraaf Jacobus; Cohen Adam F
Modeling the influence of growth hormone on lipolysis.
Journal of pharmacokinetics and pharmacodynamics 2002;29(2):157-70.
2002: Gijsman Harm J; van Gerven Joop M A; de Kam Marieke L; Schoemaker Rik C; Pieters Monique S M; Weemaes Margo; de Rijk Roel; van der Post Jeroen; Cohen Adam F
Placebo-controlled comparison of three dose-regimens of 5-hydroxytryptophan challenge test in healthy volunteers.
Journal of clinical psychopharmacology 2002;22(2):183-9.
2002: Gijsman Harm J; van Gerven Joop M A; Verkes Robbert Jan; Schoemaker Rik C; Pieters Monique S M; Pennings Ed J M; Hessing Trees J; Cohen Adam F
Saccadic peak velocity and EEG as end-points for a serotonergic challenge test.
Human psychopharmacology 2002;17(2):83-9.
2002: Ollier Céline; Faaij Richard A; Santoni Alix; Duvauchelle Thierry; van Haard Paul M M; Schoemaker Rik C; Cohen Adam F; de Greef Rik; Burggraaf Jacobus
Absence of interaction of fondaparinux sodium with aspirin and piroxicam in healthy male volunteers.
Clinical pharmacokinetics 2002;41 Suppl 2():31-7.
2002: Faaij Richard A; Burggraaf Jacobus; Schoemaker Rik C; de Greef Rik; Cohen Adam F
The synthetic pentasaccharide fondaparinux sodium does not interact with oral warfarin.
Clinical pharmacokinetics 2002;41 Suppl 2():27-9.
2001: Pijl H; de Meijer P H; Langius J; Coenegracht C I; van den Berk A H; Chandie Shaw P K; Boom H; Schoemaker R C; Cohen A F; Burggraaf J; Meinders A E
Food choice in hyperthyroidism: potential influence of the autonomic nervous system and brain serotonin precursor availability.
The Journal of clinical endocrinology and metabolism 2001;86(12):5848-53.
2001: Kemme M J; Faaij R A; Schoemaker R C; Kluft C; Meijer P; Cohen A F; Burggraaf J
Disagreement between bedside and laboratory activated partial thromboplastin time and international normalized ratio for various novel anticoagulants.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2001;12(7):583-91.
2001: Kemme M J; Burggraaf J; Schoemaker R C; Cohen A F
No Influence of acute hypertriglyceridemia on plasma t-PA in healthy male volunteers.
Thrombosis research 2001;103(1):9-16.
2001: Burggraaf J; Westendorp R G; in't Veen J C; Schoemaker R C; Sterk P J; Cohen A F; Blauw G J
Cardiovascular side effects of inhaled salbutamol in hypoxic asthmatic patients.
Thorax 2001;56(7):567-9.
2001: Burggraaf J; Tulen J H; Lalezari S; Schoemaker R C; De Meyer P H; Meinders A E; Cohen A F; Pijl H
Sympathovagal imbalance in hyperthyroidism.
American journal of physiology. Endocrinology and metabolism 2001;281(1):E190-5.
2001: Twiss I M; Burggraaf J; Schoemaker R C; van Elburg R M; den Hartigh J; Cohen A F; Vermeij P
The sugar absorption test in the evaluation of the gastrointestinal intolerance to bisphosphonates: studies with oral pamidronate.
Clinical pharmacology and therapeutics 2001;69(6):431-7.
2001: Kreilgaard M; Kemme M J; Burggraaf J; Schoemaker R C; Cohen A F
Influence of a microemulsion vehicle on cutaneous bioequivalence of a lipophilic model drug assessed by microdialysis and pharmacodynamics.
Pharmaceutical research 2001;18(5):593-9.
2001: de Visser S J; van Gerven J M; Schoemaker R C; Cohen A F
Concentration-effect relationships of two infusion rates of the imidazoline antihypertensive agent rilmenidine for blood pressure and development of side-effects in healthy subjects.
British journal of clinical pharmacology 2001;51(5):423-8.
2001: van der Vorst M M; Ruys-Dudok van Heel I; Kist-van Holthe J E; den Hartigh J; Schoemaker R C; Cohen A F; Burggraaf J
Continuous intravenous furosemide in haemodynamically unstable children after cardiac surgery.
Intensive care medicine 2001;27(4):711-5.
2001: Faaij R A; van Griensven J M; Schoemaker R C; Goggin T; Guenzi A; Kroon J M; Burggraaf J; Cohen A F
The effect of warfarin on the pharmacokinetics and pharmacodynamics of napsagatran in healthy male volunteers.
European journal of clinical pharmacology 2001;57(1):25-9.
2001: Verkes R J; Gijsman H J; Pieters M S; Schoemaker R C; de Visser S; Kuijpers M; Pennings E J; de Bruin D; Van de Wijngaart G; Van Gerven J M; Cohen A F
Cognitive performance and serotonergic function in users of ecstasy.
Psychopharmacology 2001;153(2):196-202.
2001: Langendonk J G; Veldhuis J D; Burggraaf J; Schoemaker R C; Cohen A F; Meinders A E; Pijl H
Estimation of growth hormone secretion rate: impact of kinetic assumptions intrinsic to the analytical approach.
American journal of physiology. Regulatory, integrative and comparative physiology 2001;280(1):R225-32.
2000: Burggraaf J; Kemme M J; Muller L M; Schoemaker R C; Cohen A F
The influence of the hand circulation on the assessment of venous distensibility of the human forearm with venous occlusion plethysmography.
British journal of clinical pharmacology 2000;50(6):621-3.
2000: Kemme M J; Burggraaf J; Schoemaker R C; Cohen A F; Blauw G J
No evidence for functional involvement of 5-HT2B receptors in serotonin-induced vasodilatation in the human forearm.
Journal of cardiovascular pharmacology 2000;36(6):699-703.
2000: Burggraaf J; Schoemaker R C; Lentjes E G; Cohen A F
Sorbitol as a marker for drug-induced decreases of variable duration in liver blood flow in healthy volunteers.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2000;12(2):133-9.
2000: de Roode A; van Gerven J M; Schoemaker R C; Engbers F H; Olieman W; Kroon J R; Cohen A F; Bovill J G
A comparison of the effects of propofol and midazolam on memory during two levels of sedation by using target-controlled infusion.
Anesthesia and analgesia 2000;91(5):1056-61.
2000: Weijtens O; Schoemaker R C; Lentjes E G; Romijn F P; Cohen A F; van Meurs J C
Dexamethasone concentration in the subretinal fluid after a subconjunctival injection, a peribulbar injection, or an oral dose.
Ophthalmology 2000;107(10):1932-8.
2000: Karlsson M O; Schoemaker R C; Kemp B; Cohen A F; van Gerven J M; Tuk B; Peck C C; Danhof M
A pharmacodynamic Markov mixed-effects model for the effect of temazepam on sleep.
Clinical pharmacology and therapeutics 2000;68(2):175-88.
2000: Kemme M J; Burggraaf J; Schoemaker R C; Paulson S; Karim A; Lentjes E G; Childs A; Braeckman R A; Cohen A F
The influence of reduced liver blood flow on the pharmacokinetics and pharmacodynamics of recombinant tissue factor pathway inhibitor.
Clinical pharmacology and therapeutics 2000;67(5):504-11.
2000: de Hoog M; Schoemaker R C; Mouton J W; van den Anker J N
Vancomycin population pharmacokinetics in neonates.
Clinical pharmacology and therapeutics 2000;67(4):360-7.
1999: Faaij R A; Van Gerven J M; Jolivet-Landreau I; Masclee A A; Vendrig E M; Schoemaker R C; Jacobs L D; Cohen A F
Onset of action during on-demand treatment with maalox suspension or low-dose ranitidine for heartburn.
Alimentary pharmacology & therapeutics 1999;13(12):1605-10.
1999: Langendonk J G; Meinders A E; Burggraaf J; Frölich M; Roelen C A; Schoemaker R C; Cohen A F; Pijl H
Influence of obesity and body fat distribution on growth hormone kinetics in humans.
The American journal of physiology 1999;277(5 Pt 1):E824-9.
1999: Weijtens O; Feron E J; Schoemaker R C; Cohen A F; Lentjes E G; Romijn F P; van Meurs J C
High concentration of dexamethasone in aqueous and vitreous after subconjunctival injection.
American journal of ophthalmology 1999;128(2):192-7.
1999: Voortman G; van de Post J; Schoemaker R C; van Gerven J M
Bioequivalence of subcutaneous injections of recombinant human follicle stimulating hormone (Puregon(R)) by Pen-injector and syringe.
Human reproduction (Oxford, England) 1999;14(7):1698-702.
1999: Cath D C; Gijsman H J; Schoemaker R C; van Griensven J M; Troost N; van Kempen G M; Cohen A F
The effect of m-CPP on tics and obsessive-compulsive phenomena in Gilles de la Tourette syndrome.
Psychopharmacology 1999;144(2):137-43.
1999: Faaij R A; Srivastava N; van Griensven J M; Schoemaker R C; Kluft C; Burggraaf J; Cohen A F
The oral bioavailability of pentosan polysulphate sodium in healthy volunteers.
European journal of clinical pharmacology 1999;54(12):929-35.
1999: van Steveninck A L; van Berckel B N; Schoemaker R C; Breimer D D; van Gerven J M; Cohen A F
The sensitivity of pharmacodynamic tests for the central nervous system effects of drugs on the effects of sleep deprivation.
Journal of psychopharmacology (Oxford, England) 1999;13(1):10-7.
1998: van Gerven J M; Uchida E; Uchida N; Pieters M S; Meinders A J; Schoemaker R C; Nanhekhan L V; Kroon J M; de Visser S J; Altorf B; Yasuda K; Yasuhara H; Cohen A F
Pharmacodynamics and pharmacokinetics of a single oral dose of nitrazepam in healthy volunteers: an interethnic comparative study between Japanese and European volunteers.
Journal of clinical pharmacology 1998;38(12):1129-36.
1998: van Haarst A D; van 't Klooster G A; van Gerven J M; Schoemaker R C; van Oene J C; Burggraaf J; Coene M C; Cohen A F
The influence of cisapride and clarithromycin on QT intervals in healthy volunteers.
Clinical pharmacology and therapeutics 1998;64(5):542-6.
1998: Schoemaker R C; van Gerven J M; Cohen A F
Estimating potency for the Emax-model without attaining maximal effects.
Journal of pharmacokinetics and biopharmaceutics 1998;26(5):581-93.
1998: Gijsman H J; Van Gerven J M; Tieleman M C; Schoemaker R C; Pieters M S; Ferrari M D; Cohen A F; Van Kempen G M
Pharmacokinetic and pharmacodynamic profile of oral and intravenous meta-chlorophenylpiperazine in healthy volunteers.
Journal of clinical psychopharmacology 1998;18(4):289-95.
1998: Schoemaker R C; Burggraaf J; Cohen A F
Assessment of hepatic blood flow using continuous infusion of high clearance drugs.
British journal of clinical pharmacology 1998;45(5):463-9.
1998: Burggraaf J; Schoemaker R C; Kroon J M; Cohen A F
The influence of nifedipine and captopril on liver blood flow in healthy subjects.
British journal of clinical pharmacology 1998;45(5):447-51.
1998: Weijtens O; Schoemaker R C; Cohen A F; Romijn F P; Lentjes E G; van Rooij J; van Meurs J C
Dexamethasone concentration in vitreous and serum after oral administration.
American journal of ophthalmology 1998;125(5):673-9.
1998: Langendonk J G; Pijl H; Toornvliet A C; Burggraaf J; Frölich M; Schoemaker R C; Doornbos J; Cohen A F; Meinders A E
Circadian rhythm of plasma leptin levels in upper and lower body obese women: influence of body fat distribution and weight loss.
The Journal of clinical endocrinology and metabolism 1998;83(5):1706-12.
1998: Burggraaf J; Schoemaker R C; Terpstra I J; Cohen A F
A phase I double-blind, placebo-controlled, single rising dose study to determine the safety, tolerability, and pharmacokinetics of oral YM934 in healthy male volunteers.
Journal of clinical pharmacology 1998;38(1):45-53.
1998: van Griensven J M; Koster R W; Burggraaf J; Huisman L G; Kluft C; Kroon R; Schoemaker R C; Cohen A F
Effects of liver blood flow on the pharmacokinetics of tissue-type plasminogen activator (alteplase) during thrombolysis in patients with acute myocardial infarction.
Clinical pharmacology and therapeutics 1998;63(1):39-47.
1997: van Gerven J M; Roncari G; Schoemaker R C; Massarella J; Keesmaat P; Kooyman H; Heizmann P; Zell M; Cohen A F; Dingemanse J
Integrated pharmacokinetics and pharmacodynamics of Ro 48-8684, a new benzodiazepine, in comparison with midazolam during first administration to healthy male subjects.
British journal of clinical pharmacology 1997;44(5):487-93.
1997: Dingemanse J; van Gerven J M; Schoemaker R C; Roncari G; Oberyé J J; van Oostenbruggen M F; Massarella J; Segala P; Zell M; Cohen A F
Integrated pharmacokinetics and pharmacodynamics of Ro 48-6791, a new benzodiazepine, in comparison with midazolam during first administration to healthy male subjects.
British journal of clinical pharmacology 1997;44(5):477-86.
1997: Tuk B; Oberyé J J; Pieters M S; Schoemaker R C; Kemp B; van Gerven J; Danhof M; Kamphuisen H A; Cohen A F; Breimer D D; Peck C C
Pharmacodynamics of temazepam in primary insomnia: assessment of the value of quantitative electroencephalography and saccadic eye movements in predicting improvement of sleep.
Clinical pharmacology and therapeutics 1997;62(4):444-52.
1997: de Hoog M; Schoemaker R C; Mouton J W; van den Anker J N
Tobramycin population pharmacokinetics in neonates.
Clinical pharmacology and therapeutics 1997;62(4):392-9.
1997: van Griensven J M; Koster R W; Hopkins G R; Beier H; Günzler W A; Kroon R; Schoemaker R C; Cohen A F
Effect of changes in liver blood flow on the pharmacokinetics of saruplase in patients with acute myocardial infarction.
Thrombosis and haemostasis 1997;78(3):1015-20.
1997: van Steveninck A L; Wallnöfer A E; Schoemaker R C; Pieters M S; Danhof M; van Gerven J M; Cohen A F
A study of the effects of long-term use on individual sensitivity to temazepam and lorazepam in a clinical population.
British journal of clinical pharmacology 1997;44(3):267-75.
1997: Weijtens O; van der Sluijs F A; Schoemaker R C; Lentjes E G; Cohen A F; Romijn F P; van Meurs J C
Peribulbar corticosteroid injection: vitreal and serum concentrations after dexamethasone disodium phosphate injection.
American journal of ophthalmology 1997;123(3):358-63.
1996: van Griensven J M; Huisman L G; Stuurman T; Dooijewaard G; Kroon R; Schoemaker R C; Kluft K; Cohen A F
Effects of increased liver blood flow on the kinetics and dynamics of recombinant tissue-type plasminogen activator.
Clinical pharmacology and therapeutics 1996;60(5):504-11.
1996: van Gerven J M; Schoemaker R C; Jacobs L D; Reints A; Ouwersloot-van der Meij M J; Hoedemaker H G; Cohen A F
Self-medication of a single headache episode with ketoprofen, ibuprofen or placebo, home-monitored with an electronic patient diary.
British journal of clinical pharmacology 1996;42(4):475-81.
1996: Visser W H; Burggraaf J; Muller L M; Schoemaker R C; Fowler P A; Cohen A F; Ferrari M D
Pharmacokinetic and pharmacodynamic profiles of sumatriptan in migraine patients with headache recurrence or no response.
Clinical pharmacology and therapeutics 1996;60(4):452-60.
1996: Schoemaker R C; Cohen A F
Estimating impossible curves using NONMEM.
British journal of clinical pharmacology 1996;42(3):283-90.
1996: van Steveninck A L; Gieschke R; Schoemaker R C; Roncari G; Tuk B; Pieters M S; Breimer D D; Cohen A F
Pharmacokinetic and pharmacodynamic interactions of bretazenil and diazepam with alcohol.
British journal of clinical pharmacology 1996;41(6):565-73.
1995: van Griensven J M; Burggraaf K J; Gerloff J; Günzler W A; Beier H; Kroon R; Huisman L G; Schoemaker R C; Kluft K; Cohen A F
Effects of changing liver blood flow by exercise and food on kinetics and dynamics of saruplase.
Clinical pharmacology and therapeutics 1995;57(4):381-9.
1995: van Griensven J M; Schoemaker R C; Cohen A F; Luus H G; Seibert-Grafe M; Röthig H J
Pharmacokinetics, pharmacodynamics and bioavailability of the ACE inhibitor ramipril.
European journal of clinical pharmacology 1995;47(6):513-8.
1994: Schoemaker R C; van Houwelingen H C
Repeated measures for two within-subject factors: analysis and missing data solutions.
Journal of biopharmaceutical statistics 1994;4(2):173-88.
1993: Mulders T M; Venizelos V; Schoemaker R; Cohen A F; Breimer D D; Mulder G J
Characterization of glutathione conjugation in humans: stereoselectivity in plasma elimination pharmacokinetics and urinary excretion of (R)- and (S)-2-bromoisovalerylurea in healthy volunteers.
Clinical pharmacology and therapeutics 1993;53(1):49-58.
1992: Cohen A; Boeijinga J K; van Haard P M; Schoemaker R C; van Vliet-Verbeek A
Gastrointestinal blood loss after non-steroidal anti-inflammatory drugs. Measurement by selective determination of faecal porphyrins.
British journal of clinical pharmacology 1992;33(1):33-8.
1990: Cohen A F; van Hall M A; van Harten J; Schoemaker R C; Johansson P; Breimer D D; Visser R; Edgar B
The influence of infusion rate on the hemodynamic effects of felodipine.
Clinical pharmacology and therapeutics 1990;48(3):309-17.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Rik Schoemaker

Research Profile (preview)

Procedures

Disorders

Concepts & Ideas

Chemicals & Drugs

Phenomena

Physiology

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Rik Schoemaker (preview)

All Publications